(OPY) Oppenheimer Holdings - Overview
Stock: Brokerage, Advisory, Asset-Management, Investment-Banking, Trading
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.44% |
| Yield on Cost 5y | 5.04% |
| Yield CAGR 5y | 2.80% |
| Payout Consistency | 94.7% |
| Payout Ratio | 20.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.3% |
| Relative Tail Risk | -9.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.05 |
| Alpha | 26.37 |
| Character TTM | |
|---|---|
| Beta | 0.948 |
| Beta Downside | 1.212 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.42% |
| CAGR/Max DD | 0.98 |
Description: OPY Oppenheimer Holdings December 25, 2025
Oppenheimer Holdings Inc. (NYSE: OPY) is a full-service, middle-market investment bank and broker-dealer operating across the Americas, Europe, the Middle East and Asia. Its product suite spans corporate equity and debt underwriting, municipal bonds, ETFs, options, futures, wealth-planning, margin lending, and a broad array of asset-management solutions-including separately managed accounts, discretionary portfolios, and institutional fixed-income strategies. The firm also provides investment-banking advisory, capital-markets execution, equity research, proprietary trading, and cloud-based market services to high-net-worth individuals, corporations, governments and institutional investors.
Key recent metrics: FY 2023 revenue was approximately $1.2 billion, with net income of $150 million and a return on equity of 9.5 %; assets under management (AUM) grew to roughly $50 billion, driven largely by demand for fixed-income and alternative-investment products. The sector is currently sensitive to the Federal Reserve’s interest-rate policy-higher rates boost net-interest margins on brokerage cash balances but can suppress equity underwriting volumes. Additionally, tightening capital-requirement regimes (Basel III) are pressuring middle-market banks to optimize balance-sheet efficiency, a trend Oppenheimer is addressing through its cloud-based platform and expanded fee-based services.
For a deeper, data-driven view of OPY’s valuation dynamics, you might explore the analytical tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 84.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 11.51 > 1.0 |
| NWC/Revenue: 81.37% < 20% (prev 151.3%; Δ -69.96% < -1%) |
| CFO/TA 0.02 > 3% & CFO 86.5m > Net Income 84.8m |
| Net Debt (120.5m) to EBITDA (247.7m): 0.49 < 3 |
| Current Ratio: 8.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.5m) vs 12m ago 1.53% < -2% |
| Gross Margin: 32.35% > 18% (prev 0.34%; Δ 3201 % > 0.5%) |
| Asset Turnover: 42.89% > 50% (prev 40.55%; Δ 2.34% > 0%) |
| Interest Coverage Ratio: 2.39 > 6 (EBITDA TTM 247.7m / Interest Expense TTM 87.8m) |
Altman Z'' 3.63
| A: 0.33 (Total Current Assets 1.41b - Total Current Liabilities 159.1m) / Total Assets 3.82b |
| B: 0.23 (Retained Earnings 887.7m / Total Assets 3.82b) |
| C: 0.06 (EBIT TTM 210.1m / Avg Total Assets 3.59b) |
| D: 0.31 (Book Value of Equity 890.6m / Total Liabilities 2.90b) |
| Altman-Z'' Score: 3.63 = AA |
Beneish M -1.84
| DSRI: 0.74 (Receivables 1.37b/1.64b, Revenue 1.54b/1.37b) |
| GMI: 1.05 (GM 32.35% / 34.08%) |
| AQI: 3.13 (AQ_t 0.60 / AQ_t-1 0.19) |
| SGI: 1.13 (Revenue 1.54b / 1.37b) |
| TATA: -0.00 (NI 84.8m - CFO 86.5m) / TA 3.82b) |
| Beneish M-Score: -1.84 (Cap -4..+1) = B |
What is the price of OPY shares?
Over the past week, the price has changed by +10.06%, over one month by +24.77%, over three months by +38.96% and over the past year by +39.51%.
Is OPY a buy, sell or hold?
What are the forecasts/targets for the OPY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37 | -60% |
| Analysts Target Price | 37 | -60% |
| ValueRay Target Price | 113.1 | 22.3% |
OPY Fundamental Data Overview January 31, 2026
P/S = 0.5518
P/B = 0.8712
P/EG = 12.0
Revenue TTM = 1.54b USD
EBIT TTM = 210.1m USD
EBITDA TTM = 247.7m USD
Long Term Debt = 563.7m USD (from longTermDebt, last quarter)
Short Term Debt = 158.8m USD (from shortTermDebt, last quarter)
Debt = 158.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 120.5m USD (from netDebt column, last quarter)
Enterprise Value = 922.3m USD (801.8m + Debt 158.8m - CCE 38.3m)
Interest Coverage Ratio = 2.39 (Ebit TTM 210.1m / Interest Expense TTM 87.8m)
EV/FCF = 11.65x (Enterprise Value 922.3m / FCF TTM 79.2m)
FCF Yield = 8.59% (FCF TTM 79.2m / Enterprise Value 922.3m)
FCF Margin = 5.14% (FCF TTM 79.2m / Revenue TTM 1.54b)
Net Margin = 5.50% (Net Income TTM 84.8m / Revenue TTM 1.54b)
Gross Margin = 32.35% ((Revenue TTM 1.54b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 30.01% (prev 34.05%)
Tobins Q-Ratio = 0.24 (Enterprise Value 922.3m / Total Assets 3.82b)
Interest Expense / Debt = 14.16% (Interest Expense 22.5m / Debt 158.8m)
Taxrate = 31.37% (9.92m / 31.6m)
NOPAT = 144.2m (EBIT 210.1m * (1 - 31.37%))
Current Ratio = 8.88 (Total Current Assets 1.41b / Total Current Liabilities 159.1m)
Debt / Equity = 0.17 (Debt 158.8m / totalStockholderEquity, last quarter 920.3m)
Debt / EBITDA = 0.49 (Net Debt 120.5m / EBITDA 247.7m)
Debt / FCF = 1.52 (Net Debt 120.5m / FCF TTM 79.2m)
Total Stockholder Equity = 884.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.36% (Net Income 84.8m / Total Assets 3.82b)
RoE = 9.58% (Net Income TTM 84.8m / Total Stockholder Equity 884.9m)
RoCE = 14.50% (EBIT 210.1m / Capital Employed (Equity 884.9m + L.T.Debt 563.7m))
RoIC = 9.46% (NOPAT 144.2m / Invested Capital 1.52b)
WACC = 9.46% (E(801.8m)/V(960.6m) * Re(9.41%) + D(158.8m)/V(960.6m) * Rd(14.16%) * (1-Tc(0.31)))
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.64%
[DCF Debug] Terminal Value 63.91% ; FCFF base≈79.2m ; Y1≈52.0m ; Y5≈23.7m
Fair Price DCF = 23.97 (EV 370.4m - Net Debt 120.5m = Equity 249.8m / Shares 10.4m; r=9.46% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 28.73 | EPS CAGR: -21.05% | SUE: N/A | # QB: 0
Revenue Correlation: 73.60 | Revenue CAGR: 4.10% | SUE: N/A | # QB: 0